Antimicrobial agents | Community‐acquired biliary infection | HeaIthcare‐associated biliary infection | ||
Grade I Cholecystitis and cholangitis |
Grade II Cholecystitis and cholangitis |
Grade III Cholecystitis and cholangitis |
Cholecystitis and cholangitis | |
Penicillin‐based therapy | Ampicillin/sulbactam | Piperacillin/tazobactam | Piperacillin/tazobactam | Piperacillin/tazobactam |
Cephalosporin‐based therapy | Cefazolin, or cefuroxime, or ceftriaxone, or cefotaxime ± metronidazole, cefmetatole, cefoxitin flomoxef, cefoperazone/sulbactam |
Ceftriaxone, or cefotaxime, or cefepime, or cefozopran, or ceftazidime, ± metronidazole, cefoperazone/sulbactam |
Cefepime, or ceftazidime, or cefoperazon ± metronidazole |
Cefepime, or ceftazidime, or cefoperazon ± metronidazole |
Carbapenem‐based therapy | Ertapenem | Ertapenem | Imipenem/cilastatin, meropenem, doripenem, ertapenem | Imipenem/cilastatin, meropenem, doripenem, ertapenem |
Monobactam‐based therapy | — | — | Aztreonam ± metronidazole | Aztreonam ± metronidazole |
Fluoroquinolone‐based therapy | Ciprofloxacin, levofloxacin, pazufloxacin ± metronidazole, moxifloxacin | Ciprofloxacin, levofloxacin, pazufloxacin ± metronidazole, moxifloxacin |
— | — |